Kidney dysfunction in the recipients of liver transplants
Key Points 1 Pretransplant kidney function is an important predictor of posttransplant kidney function. 2 Chronic kidney disease is present in 20% of liver transplant recipients by 5 years. 3 Kidney function is impacted by pretransplant management of the consequences of the hepatorenal syndrome. 4 T...
Gespeichert in:
| Veröffentlicht in: | Liver transplantation 2005-11, Vol.11 (S2), p.S47-S51 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | S51 |
|---|---|
| container_issue | S2 |
| container_start_page | S47 |
| container_title | Liver transplantation |
| container_volume | 11 |
| creator | Wilkinson, Alan Pham, Phuong‐Thu |
| description | Key Points
1
Pretransplant kidney function is an important predictor of posttransplant kidney function.
2
Chronic kidney disease is present in 20% of liver transplant recipients by 5 years.
3
Kidney function is impacted by pretransplant management of the consequences of the hepatorenal syndrome.
4
The use of calcineurin inhibitor (CNI)–based immunosuppression is an important factor in the development of chronic kidney disease, and the use of mycophenolic acid– or sirolimus‐based immunosuppression with reduced‐dose CNI may be of benefit. (Liver Transpl 2005;11:S47–S51.) |
| doi_str_mv | 10.1002/lt.20618 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68729343</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68729343</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4198-aacf9bfc9fe8a7b6a2b3d539835d126dc58c932bd4b55722852db7fdc6c63b6e3</originalsourceid><addsrcrecordid>eNp1kMtKxDAUQIMozjgKfoF0JW465tEkzVIGX1hwM65DnhjptDVplf691Q66cnUvl8PhcgA4R3CNIMTXdb_GkKHyACwRxTxnBSeHvzujC3CS0huECFEBj8ECMUw4R8USiKdgGzdmdkx-aEwf2iYLTda_uiw6E7rgmj5lrc_q8OFi1kfVpK5W0_EUHHlVJ3e2nyvwcne73Tzk1fP94-amyk2BRJkrZbzQ3gjvSsU1U1gTS4koCbUIM2toaQTB2haaUo5xSbHV3FvDDCOaObICl7O3i-374FIvdyEZV09PuHZIkpUcC1KQCbyaQRPblKLzsothp-IoEZTfmWTdy59ME3qxdw565-wfuO8yAfkMfIbajf-KZLWdhV9oQHD8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68729343</pqid></control><display><type>article</type><title>Kidney dysfunction in the recipients of liver transplants</title><source>MEDLINE</source><source>Wiley Online Library Journals</source><source>Alma/SFX Local Collection</source><creator>Wilkinson, Alan ; Pham, Phuong‐Thu</creator><creatorcontrib>Wilkinson, Alan ; Pham, Phuong‐Thu</creatorcontrib><description>Key Points
1
Pretransplant kidney function is an important predictor of posttransplant kidney function.
2
Chronic kidney disease is present in 20% of liver transplant recipients by 5 years.
3
Kidney function is impacted by pretransplant management of the consequences of the hepatorenal syndrome.
4
The use of calcineurin inhibitor (CNI)–based immunosuppression is an important factor in the development of chronic kidney disease, and the use of mycophenolic acid– or sirolimus‐based immunosuppression with reduced‐dose CNI may be of benefit. (Liver Transpl 2005;11:S47–S51.)</description><identifier>ISSN: 1527-6465</identifier><identifier>EISSN: 1527-6473</identifier><identifier>DOI: 10.1002/lt.20618</identifier><identifier>PMID: 16237714</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Calcineurin Inhibitors ; Graft Rejection - prevention & control ; Humans ; Immunosuppressive Agents - adverse effects ; Immunosuppressive Agents - therapeutic use ; Kidney Failure, Chronic - etiology ; Kidney Failure, Chronic - metabolism ; Liver Transplantation - adverse effects ; Risk Factors</subject><ispartof>Liver transplantation, 2005-11, Vol.11 (S2), p.S47-S51</ispartof><rights>Copyright © 2005 American Association for the Study of Liver Diseases</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4198-aacf9bfc9fe8a7b6a2b3d539835d126dc58c932bd4b55722852db7fdc6c63b6e3</citedby><cites>FETCH-LOGICAL-c4198-aacf9bfc9fe8a7b6a2b3d539835d126dc58c932bd4b55722852db7fdc6c63b6e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Flt.20618$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Flt.20618$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16237714$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wilkinson, Alan</creatorcontrib><creatorcontrib>Pham, Phuong‐Thu</creatorcontrib><title>Kidney dysfunction in the recipients of liver transplants</title><title>Liver transplantation</title><addtitle>Liver Transpl</addtitle><description>Key Points
1
Pretransplant kidney function is an important predictor of posttransplant kidney function.
2
Chronic kidney disease is present in 20% of liver transplant recipients by 5 years.
3
Kidney function is impacted by pretransplant management of the consequences of the hepatorenal syndrome.
4
The use of calcineurin inhibitor (CNI)–based immunosuppression is an important factor in the development of chronic kidney disease, and the use of mycophenolic acid– or sirolimus‐based immunosuppression with reduced‐dose CNI may be of benefit. (Liver Transpl 2005;11:S47–S51.)</description><subject>Calcineurin Inhibitors</subject><subject>Graft Rejection - prevention & control</subject><subject>Humans</subject><subject>Immunosuppressive Agents - adverse effects</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Kidney Failure, Chronic - etiology</subject><subject>Kidney Failure, Chronic - metabolism</subject><subject>Liver Transplantation - adverse effects</subject><subject>Risk Factors</subject><issn>1527-6465</issn><issn>1527-6473</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtKxDAUQIMozjgKfoF0JW465tEkzVIGX1hwM65DnhjptDVplf691Q66cnUvl8PhcgA4R3CNIMTXdb_GkKHyACwRxTxnBSeHvzujC3CS0huECFEBj8ECMUw4R8USiKdgGzdmdkx-aEwf2iYLTda_uiw6E7rgmj5lrc_q8OFi1kfVpK5W0_EUHHlVJ3e2nyvwcne73Tzk1fP94-amyk2BRJkrZbzQ3gjvSsU1U1gTS4koCbUIM2toaQTB2haaUo5xSbHV3FvDDCOaObICl7O3i-374FIvdyEZV09PuHZIkpUcC1KQCbyaQRPblKLzsothp-IoEZTfmWTdy59ME3qxdw565-wfuO8yAfkMfIbajf-KZLWdhV9oQHD8</recordid><startdate>200511</startdate><enddate>200511</enddate><creator>Wilkinson, Alan</creator><creator>Pham, Phuong‐Thu</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200511</creationdate><title>Kidney dysfunction in the recipients of liver transplants</title><author>Wilkinson, Alan ; Pham, Phuong‐Thu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4198-aacf9bfc9fe8a7b6a2b3d539835d126dc58c932bd4b55722852db7fdc6c63b6e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Calcineurin Inhibitors</topic><topic>Graft Rejection - prevention & control</topic><topic>Humans</topic><topic>Immunosuppressive Agents - adverse effects</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Kidney Failure, Chronic - etiology</topic><topic>Kidney Failure, Chronic - metabolism</topic><topic>Liver Transplantation - adverse effects</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wilkinson, Alan</creatorcontrib><creatorcontrib>Pham, Phuong‐Thu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Liver transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wilkinson, Alan</au><au>Pham, Phuong‐Thu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kidney dysfunction in the recipients of liver transplants</atitle><jtitle>Liver transplantation</jtitle><addtitle>Liver Transpl</addtitle><date>2005-11</date><risdate>2005</risdate><volume>11</volume><issue>S2</issue><spage>S47</spage><epage>S51</epage><pages>S47-S51</pages><issn>1527-6465</issn><eissn>1527-6473</eissn><abstract>Key Points
1
Pretransplant kidney function is an important predictor of posttransplant kidney function.
2
Chronic kidney disease is present in 20% of liver transplant recipients by 5 years.
3
Kidney function is impacted by pretransplant management of the consequences of the hepatorenal syndrome.
4
The use of calcineurin inhibitor (CNI)–based immunosuppression is an important factor in the development of chronic kidney disease, and the use of mycophenolic acid– or sirolimus‐based immunosuppression with reduced‐dose CNI may be of benefit. (Liver Transpl 2005;11:S47–S51.)</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>16237714</pmid><doi>10.1002/lt.20618</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1527-6465 |
| ispartof | Liver transplantation, 2005-11, Vol.11 (S2), p.S47-S51 |
| issn | 1527-6465 1527-6473 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68729343 |
| source | MEDLINE; Wiley Online Library Journals; Alma/SFX Local Collection |
| subjects | Calcineurin Inhibitors Graft Rejection - prevention & control Humans Immunosuppressive Agents - adverse effects Immunosuppressive Agents - therapeutic use Kidney Failure, Chronic - etiology Kidney Failure, Chronic - metabolism Liver Transplantation - adverse effects Risk Factors |
| title | Kidney dysfunction in the recipients of liver transplants |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T16%3A50%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kidney%20dysfunction%20in%20the%20recipients%20of%20liver%20transplants&rft.jtitle=Liver%20transplantation&rft.au=Wilkinson,%20Alan&rft.date=2005-11&rft.volume=11&rft.issue=S2&rft.spage=S47&rft.epage=S51&rft.pages=S47-S51&rft.issn=1527-6465&rft.eissn=1527-6473&rft_id=info:doi/10.1002/lt.20618&rft_dat=%3Cproquest_cross%3E68729343%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68729343&rft_id=info:pmid/16237714&rfr_iscdi=true |